The MinMed Paradigm™ Veo™ System is the world’s first insulin pump equipped with Low Glucose Suspend (LGS) – an automatic insulin shut-off mechanism for when your glucose falls below a pre-set limit.

Imagine, for example, that your glucose level begins to fall. Using sensor data, the Paradigm Veo System will sound an alert so you can take action to prevent or minimise a hypoglycaemic event. If you don’t respond to this alert and then reach your pre-set low, a further warning will sound. If you then fail to respond to this warning, the Paradigm Veo System will automatically halt insulin delivery for two hours.

At Medtronic, we one day hope to develop a fully automatic product that will monitor glucose levels and deliver the right amount of insulin without any user intervention at all. With the Paradigm Veo System, we have taken a huge stride in this direction, bringing us another step closer to closing the loop.